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Abstract
The trigeminal nerve constitutes the largest sensory cortex representation
in the brain compared with other sensory nerves. This is likely due to the
fact that the trigeminal nerve underpins our very existence, as it
sensorially protects, our five senses including the organs that provide
sight, smell, taste, hearing, speech and meninges protecting our brain.
Thus, when trigeminal nerve injuries occur, which in the main are
preventable and painful, the majority of patients experience mixed
symptoms including altered sensation, numbness and ongoing or elicited
neuropathic pain. These neuropathic features cause significant impact on
the patients’ ability to function, for example cold allodynia prevents the
patient enjoying cold foods and drinks and undertaking out-door activities
or mechanical allodynia frequently interferes with eating, speaking,
kissing and sleep. The resultant chronic symptoms and functional
impedance result in significant psychological morbidity. Prevention of
nerve injuries related to local anaesthesia (LA), endodontics, implants and
third molar surgery is imperative as there is no magic bullet to repair
these sensory nerve injuries with their related neuropathic pain. Some
causes have higher levels of resolution (third molar surgery and LA) some
lower levels of resolution (implant surgery and endodontics) and many
patient factors will dictate the prevalence of chronic neuropathic pain.
The patient must have appropriate consent and their expectations
managed with understanding the potential benefits and risks for their
chosen interventions. The authors have aimed to provide an up to date
evidence base for diagnosis and management of trigeminal nerve injuries.
Background
Trigeminal nerve injury (TNI) and subsequent post-
traumatic trigeminal neuropathic pain (PTNP), is a
problematic consequence of dental or oromaxillofacial
surgical procedures with major medico-legal implica-
tions.1 The incidence of lingual nerve injury has
remained static in the UK over the last 30 years, but is
increasing in the US, as is the incidence of inferior alve-
olar nerve (IAN) injury in the UK; the latter being due
to implant surgery and endodontic therapy.2 Trigemi-
nal nerve injuries are generally classified as temporary
but can persist and become permanent (by definition
after 3 months). Based upon the limited evidence base,
nerve injuries caused by implant and endodontic treat-
ments are mainly painful and permanent.3 Temporary
nerve injuries are more likely related to local anaesthe-
sia (LA) or third molar surgery, with mandibular
related surgery patients are advised that the rate of per-
manent inferior alveolar or lingual nerve injuries occur
between 0.1–2% of cases.4,5 LA nerve injuries have a
75% likelihood of recovery.6,7
The fifth cranial nerve divisions two and three are
the most commonly damaged, caused by implants,
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endodontics and third molar surgery (or other high-
risk extractions).8 Nerve damage from surgery can
cause chronic postsurgical pain, however, PTNP and
chronic postsurgical pain appears to be limited in
dentistry and maxillofacial surgery (3–5%)9–11, likely
as a result of local anaesthetic (LA) infiltration injec-
tions preventing peripheral and central sensitisation
(Fig. 1). However, the true incidence of trigeminal
nerve injuries is not known due to the fact that
many procedures occur in private practices and inci-
dents are underreported. Other common general sur-
gical procedures cause chronic postsurgical pain in
20–45% of patients after surgical limb amputation,
thoracotomy and breast surgery for example.12,13
Many of these chronic postsurgical pain patients
actually experience neuropathic pain.14,15
Iatrogenic (caused by surgery or medicine) trigem-
inal nerve injuries, result in pain in 70% of patients
seen seeking treatment in our clinics.16 The ongoing
or evoked pain results in interference with eating,
speaking, sleeping, applying makeup, shaving, kiss-
ing, tooth brushing and drinking; just about every
social interaction we take for granted. As a result,
these injuries have a significant negative effect on
the patient’s self-image, quality of life and psychol-
ogy.16
Risk factors
Risk factors for chronic postsurgical pain (not limited
to PTNP) are many (Table 1), highlighting, the
Figure 1 Diagram illustrating the peripheral and central changes after peripheral sensory nerve injury.
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complexity of predisposition to persistent pain due to
sensory nerve injury.17
Nerve damage is likely to result from a combina-
tion of poor risk assessment, poor technique and late
recognition or management of intraoperative and
post-operative signs of neuropathy. Risk assessment
involves the patient selection, preoperative planning,
both clinical and radiographic and suitable treatment
protocol and follow up (Table 2 summarises the sur-
gical risk factors associated with trigeminal nerve
injuries and how to avoid them). It is important that
the clinician is familiar with the nerve injury risk
factors, specific for each of the type of invasive pro-
cedures. For example, in the case of protrusion
through the inferior dental canal (IDC) and resultant
direct IAN mechanical injury by implant drill a ‘sud-
den give’ or an ‘electric shock’ type feeling or high
level sudden pain, even with working under LA, is
reported by most of the patients seen on our clinic
with LA, extraction, implant or endodontic related
PTNP. This should result in the clinician stopping
surgery, not reaching for another LA block injection
and reassessing their surgical position (implant or
endodontic) with regard the injured nerve. The
problem with implant related nerve injuries is that
they are entirely avoidable as this is elective surgery,
and likely to be permanent and painful for the
patient.16 However, we must state that even in the
best hands, a nerve injury can still occur despite the
world’s best will to avoid it. This is inherent to the
surgical specialty.
Pathophysiology
It is pertinent to recognise that the trigeminal neural
pathways have important differences compared to
the spinal nerves. The proprioceptive trigeminal
afferents are the only first neuron fibres to have
their cell bodies in the central nervous system
(CNS). This not the only basic morphological differ-
ence where the fifth cranial nerve differs from other
sensory nerves. The nuclei for the TN including
motor, sensory and special sensory nuclei, are all
embedded in the midbrain and not the spinal sys-
tem. The trigeminocervical complex converging
input from C2 and C3 likely explains the often
comorbid head and neck pains or autonomic signs
and symptoms seen in chronic trigeminal pain,
including PTNP.18 In addition, these interactions as
well as close anatomical relationship between the
trigeminal sensory nuclei and other cranial nerves
(7th, 8th and 9th) may relate to referred pain and
symptoms in these nerve distributions as well. A
well-known interconnection between the fifth and
seventh cranial nerve is tested by performing the
Table 1 Risk factors for chronic postsurgical pain
Preoperative factors
Pain, moderate to severe, lasting more than 1 month
Repeated surgery
Psychological vulnerability (e.g. catastrophising)
Preoperative anxiety
Female gender
Older age
Workers’ compensation
Genetic predisposition
Inefficient diffuse noxious inhibitory control (DNIC)—a descending
pathway of pain inhibition
Intraoperative factors
Surgical approach with risk of nerve damage
Post-operative factors
High pain experience (severe)
Radiation therapy to area
Neurotoxic chemotherapy
Depression
Psychological vulnerability
Neuroticism anxiety
Table 2 Surgical risk factors
Dental local anaesthesia
(LA)
• Block anaesthesia
• Lingual nerve > inferior alveolar nerve
• Concentration and type of LA agent
• Multiple block injections
• Severe pain on injection
Third molar surgery
Lingual nerve
• Increased patient age
• Increased duration of surgery
• Lingual access surgery
• Inexperience of surgeon
• Depth of impaction of mandibular wis-
dom tooth
Third molar surgery
Inferior alveolar
nerve
• Proximity to inferior alveolar nerve
• And other lingual nerve risk factors
above
Dental implants • Proximity of IDC to planned surgical site
(mental loop, characteristics of IDC position
in various sites of mandible). Safety zone-
the recommendation is 2 mm. This may be
insufficient considering that mots implant
drills are 1.5 mm longer than implants
• Longer implants >10 mm
• Prevention using drill stops, surgical
guides, preoperative 3D planning, intra
operative radiographs
Endodontics • Proximity of tooth apex to the IDC
• Root and bone defects that allow chemi-
cal to leak from root into local bone area
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© 2019 The Authors. Oral Surgery published by British Association of Oral Surgeons and John Wiley & Sons Ltd.
3
Renton & Van der Cruyssen Surgical trigeminal nerve injuries
corneal reflex. Despite structural differences between
the trigeminal somatosensory system and other
spinal sensory nerves, there are many similarities
with the somatosensory system of the rest of the
body, for example using a common channel, the
Transient Receptor Potential Cation Channel Sub-
family M member 8 (TRPM8), for recognising cold
sensations.19 A more in depth comparison of chan-
nels and transmitters is not within the scope of this
article but we refer the readers to the included refer-
ences.19–21
A normally functioning sensory system depends
on the maintenance of equilibrium between the
neurons and their environment.22 Sequence of
events after nerve injury are described below.
Peripheral nervous system
• Changes in the equilibrium, as caused by nerve dam-
age, leading to a cascade of events progressing from the
peripheral to the CNS.23 During this stage, the presence
of inflammatory mediators released during the tissue
injury and from the recruited immune cells leads to
increased sodium and calcium channel currents, which
reduce the thresholds of the nociceptors in the periph-
eral nervous system (PNS).17 This increased sensitivity
at the site of injury is called peripheral sensitisation
(primary hyperalgesia and allodynia).23
• After peripheral injury adenosine triphosphate
(ATP) signal transduction induces activation of both
cell types further contributing in an inflammatory
cascade.24 The vesicular nucleotide transporter regu-
lates ATP release and could be a potential pharmaco-
logical target. Another channel, the subunit a2/d-1
of the L-type channel of the dihydropyridine recep-
tor, has shown to be highly selective for gabapentin
and is abundantly present in the trigeminal neurons.
Other key molecules in pain transmission are CGRP
and nitric oxide that are released after inflammation
occurs, causing upregulation of neurokinin 1 (NK1)
receptors. This upregulation causes a higher
excitability of the trigeminal neurons. The NK1
receptors are also present in the glial cells.
• Neuropeptides, neurotransmitters and channels
◦ Nerve growth factor (NGF) plays a role in neu-
ral navigation of axonal growth. NGF is also
upregulated in the trigeminal ganglion (TG) and
nucleus.25–27
◦ Calcitonin gene related peptide (CGRP), Sub-
stance P and Neuropeptide Y expression in TG
cells increases in response to injury.28
◦ Sodium voltage gated channels related to pain
including, Nav 1.8 and 1.9, are linked to severity
of pain after lingual nerve injuries.29,30 A study
reported changes in the expression pattern of
growth associated protein 43 in the IAN region of
the TG. An increase in myelination and axon den-
sity of regenerated fibres was associated with the
overall recovery process.31
• Paracrine effects cause simultaneous release of IL-1
b that in turn suppresses voltage-gated potassium
channels through protein kinase C/G protein-cou-
pled pathways, which ultimately increases the neural
excitability. Studies showed the desirable effect of
NK1 blockade at the TG to prevent central sensitisa-
tion. Eugenol is a potential inhibitor of the voltage-
gated potassium, calcium and sodium channels as
well as the hyperpolarisation-activated cyclic nucleo-
tide-gated (HCN) channels. The HCN channels have
been identified as key factors in mechanical allody-
nia.32
• An extensive review by Holland reports the mor-
phological structural and electrophysiological post-
injury changes after peripheral sensory nerve of the
TG in cats.33 Crush injuries recovered faster with less
central disruption than transection injury, chemical
nerve injuries were not evaluated. All nerve injuries
resulted in lower conduction velocities and sensory
impairment. When immediate re-apposition of cut
ends is performed no cell death occurred; however,
proximal degeneration and distal Wallerian degener-
ation were seen as well as axonal sprouting. Associ-
ated degenerative changes of brainstem nuclei were
observed. If neural gaps were needed to be covered,
stretching the nerve after release from its connective
tissues resulted in better functional results compared
to neural grafting.
• Traumatic injury to a peripheral nerve, at the dis-
tal stump of the nerve fibre, causes Wallerian degen-
eration at the distal ends of the damaged nerve.34,35
Schwann cells, responsible for providing trophic sup-
port to the nerve fibres, begin to degenerate and lose
their myelin or encapsulation in cases of unmyeli-
nated nerves.36
• Schwann cells and their recruited immune cells,
clear the debris and release (neuro)-trophic factors
that facilitate axonal growth.37
Central consequences—trigeminal ganglion
and secondary/ tertiary neurons
The understanding of the structural and molecular
changes causing central sensitisation is limited.38
• Membrane excitability changes with lower resting
membrane potentials causing lower thresholds for
transduction.
Oral Surgery  (2019) –.
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• Reduction of synaptic activity (with reduced
release of inhibitory neurotransmitters), number,
inhibition by inhibitory interneurons caused by less
transmitter synthesis, and vesicular transport and
postsynaptic lower receptor sensitivity.
• Descending tracts facilitate further in the release of
postsynaptic potentials.
• Sprouting starts enhancing excitatory synapses fur-
ther.
• Polysynaptic pathways start to form, causing
epileptiform activity with burst-like discharges and
synchronisation.
• Increased excitability and synaptic plasticity lead to
central sensitisation causing hyperalgesia, allodynia,
hyperpathia and aftersensations. This process initi-
ates as early as two days after injury or inflamma-
tion and increases when the nociceptor input has
halted. This altered pain perception and processing
has been evaluated in other pain conditions such as
fibromyalgia, migraine-type headache, temporo-
mandibular disorders, rheumatoid arthritis and
others.
• Neuropeptides. The chronic constriction sensory
nerve injury model in rats revealed
◦ A decrease in substance P immunoreactivity at
60 days after injury in the spinal dorsal horn
bilaterally.
◦ Neuropeptides changes were also observed up
to 120 days after injury. Decline in GABA-im-
munoreactive neurons starts at 896 h after injury
bilaterally, with recovery normal levels are
resumed at 8 weeks.
◦ Glutamate decarboxylase immunoreactive cells
also decline after injury, in combination with
synaptic changes, for example, long-term potenti-
ation (LTP), central sensitisation gradually
becomes clinically apparent and reduces the
chance for reversal. The electrophysiological path-
way starting at the nociceptive fiber projecting to
the TG after action potential firing.
◦ Excitatory postsynaptic potentials induce presy-
naptic transmitter release as well as an enhanced
postsynaptic transmitter effect: LTP.
• The continued activity post injury may also lead to
maladaptive plasticity in the CNS, that is, increase in
the synaptic strength leading to easier activation of
nociceptors with what were previously subthreshold
stimuli and an enhancement of the receptive fields.39
Therefore, the uninjured area surrounding the site of
damage (or even contralateral area in unilateral
nerve damage) also becomes sensitised to mechanical
inputs.22,39 This uncoupling of the stimulus intensity
and stimulus location due to the CNS plasticity is
called central sensitisation.39
Diagnosis
Diagnostic criteria
A TNI can be defined as an injury to the trigeminal
nervous tissues. After injury has been inflicted, a
painful or non-painful trigeminal neuropathy may
develop. When pain arises as a consequence of this
nerve injury and certain criteria are met (see below),
then one may speak of a neuropathic pain. Cur-
rently, the International Association for the Study of
Pain (IASP) defines neuropathic pain as ‘pain caused
by a lesion or disease of the somatosensory nervous
system.’ A grading system to aid in diagnosing neu-
ropathic pain has been proposed as well.40 The diag-
nostic criteria for pain due to trigeminal nerve
damage, presently termed as painful post-traumatic
trigeminal neuropathy (PPTTN) in the latest Interna-
tional Classification of Headache Disorders, 3rd edi-
tion (ICHD-3)41 are:
• Facial and/or oral pain in the distribution(s) of one
or both trigeminal nerve(s) and fulfilling criterion C
• History of an identifiable traumatic event to the
trigeminal nerve(s), with clinically evident positive
(hyperalgesia, allodynia) and/or negative (hypoaes-
thesia, hypoalgesia) signs of trigeminal nerve dys-
function
• Evidence of causation demonstrated by both of the
following: a. pain is localised to the distribution(s) of
the trigeminal nerve(s) affected by the traumatic
event, b. pain has developed <6 months after the
traumatic event (up to 6 months to allow for develop-
ment of neuropathy after chemotherapy and radiation.
Many surgical injuries have immediate onset, but it is pos-
sible that the pain only comes on after a few days or
weeks.)
• Not better accounted for by another ICHD-3 diag-
nosis.
These criteria are very similar to newly suggested
criteria proposed by an international collaborative
group of orofacial pain and headache researchers
under the name of International Classification of
Orofacial Pain (ICOP) version 1.0 beta (draft for
review) 2019. In the ICOP, PTTN has been slightly
renamed to PTNP. Both the ICHD-3 and ICOP pre-
sent diagnostic criteria for PTTN/PTNP, and the crite-
ria B and D from above can be used for non-painful
post-traumatic trigeminal neuropathy (nPTTN) for
patients with trigeminal nerve damage without any
Oral Surgery  (2019) –.
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associated neuropathic pain. A recent review has
highlighted some limitations in diagnosis of post-
surgical neuropathy and pain in the trigeminal
system.42
Clinical assessment
When assessing patients with surgically induced
nerve injuries we recommend a holistic
approach.43,44 We must treat the patient with the
nerve injury not just the nerve injury. Many of
these patients have experienced an unexpected trau-
matic event which demands a thorough history tak-
ing and examination including attention for sensory
testing and psychological assessment. These elements
are necessary both in diagnosis and in the choice of
therapy.
Features of iatrogenic TNI worthy of assessment
include:
• Focal sensory neuropathy (mostly present). There
is almost always an area of sensory deficit (i.e. often
with a mixture of pain, numbness and altered sensa-
tion). There may be positive (elicited pain = me-
chanical allodynia or hyperalgesia) or negative signs
(numbness = anaesthesia, expanded two-point dis-
crimination, reduced light touch). This is an impor-
tant diagnostic feature for sensory nerve neuropathy.
• Pain, discomfort, altered sensation, numbness
(anaesthesia). Neuropathic pain, a positive sign,
commonly presents with mechanical allodynia (pain
to a non-noxious stimuli), mechanical hyperalgesia
(increased pain to a noxious stimuli) and hyper-
pathia (continued altered sensation or pain after
stimulation ceases). Fifty to seventy percentage of
patients report a combination of numbness, altered
sensation and pain is experienced, the pain may be
either spontaneous ongoing pain, which often had
a burning character, and spontaneous shooting,
electric shock-like sensations (neuralgia).16 Evoked
pain due to touch (mechanical allodynia) or cold
(thermal allodynia) often leads patients to having
difficulties with daily function, such as eating,
socialising, kissing, speaking, drinking and tooth
brushing.16
Psychological factors (anxiety, stress, depression,
post-traumatic stress disorder and anger) are
related to PTNP45 and as a consequence, the
patients are often anxious, tearful due to the psy-
chological repercussions of surgery. The presence of
anxiety or depression has been suggested to nega-
tively affect treatment outcomes in other pain con-
ditions.46 In striving for better outcomes, it is
therefore advisable to also pay attention to the
psychological impact. Psychological assessment
requires the use of validated questionnaires explor-
ing anxiety, depression, post-traumatic stress disor-
der, catastrophising and somatisation. These
symptoms are often compounded by the lack of
appropriate urgent or continued management by
the treating clinician and informed consent, which
is given by only 30% of patients, most of whom
are not specifically warned about potential nerve
injury.16
Mechanosensory assessment
The clinical phenotype of somatosensory function in
trigeminal nerve damage includes both positive and
negative symptoms, which may be associated with
spontaneous or evoked pain. Clinical mechanosen-
sory tests are summarised in Figure 2. These clinical
mechanosensory tests have been shown to have a
high specificity however they have a low sensitivity.
Additional quantitative sensory testing (QST) or
emerging imaging technologies such as magnetic res-
onance neurography or multimodal assessments can
aid in further diagnostics.47,48
The positive symptoms may be represented by, for
example, dysesthesias and negative symptoms, for
example, numbness.49,50 These symptoms are more
pronounced and clinically detectable when a major
nerve branch is involved.49 In PTNP, the pain is gen-
erally of moderate to severe intensity, continuous in
nature, lasts for most of the day, and is present on
most days.16,51 Thus the patient generally presents
with hyperaesthesia or hypoaesthesia, the latter is
generally better tolerated.
Management
Decision on managing the patient with a nerve injury
is based upon the holistic assessment of the patient.
The clinician must assess the degree and impact of
the nerve injury and the type of patient. Some
patients may present with large painful neuropathies
but are happy to continue as is with minimal life
impact, whereas others may present with small areas
of neuropathy with no pain but significant related
functional and psychological impact. As with all deci-
sions in life there are benefits and risks with any
intervention. No reparative surgery or chronic pain
medication is devoid of side effects or potential risks.
The patient has to be made aware of the diagnosis,
prognosis and possible interventions with associated
risks and benefits. This is a long conversation and
may need to take place over several consultations.
Oral Surgery  (2019) –.
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Examination protocol for mechanosensory evaluation of the extraoral dermatome of V3. This protocol could
also be applied to other dermatomes.
Area affected
Using forceps run over normal to neuropathic area warning the patient 
that there may be hypersensitivity as well as hyposensitivity. 
Map out the area and record pictorially or by photograph using pen 
marks on patient's face.
Estimate the % or extra-oral dermatome is affected by the neuropathy.
(yellow dotted lines indicate V3 dermatome and arrows indicate 
direction of testing from normal to neuropathic area)
Subjective function
Using forceps with beaks together firmly tap (minimum 5 times) the 
patient's hand several times explaining that is 'normal' 10 out of 10 
subjective function. Then tap, with the same pressure, over the 
unaffected side of the face or tongue and repeat the stimulation 
explaining that should be 10 out of 10. 
Move your forceps away and explain no stimulation at all is 0 out of 10. 
Repeat over neuropathic area that you have already confirmed and ask 
the patient to report the level of stimulus according to the NRS scale 
below.
0 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20
Hypoaesthesia Hyperaesthesia
No stimulus response Normal function Worst stimulus intensity imaginable
This test can be repeated over different domains of the neuropathy (lip 
vermillion, lip skin and chin skin or over tongue)
Light touch
To evaluate light touch thresholds von Frey filaments are highly 
recommended. If these are not be available, a pledget can be used 
instead, placing repeated (minimum 5 times) on normal side first then 
repeated on affected side; ask the patient to report di fferences. If the 
patient is experiencing numbness on stimulation, they will have reduced 
light touch detection thresholds. However, if the patient is suffering from 
hyperaesthesia and possible allodynia (pain on touch) this test can be 
very uncomfortable.
Figure 2 Mechanosensory tests for routine assessment of surgical trigeminal nerve injuries.
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Many nerve injuries require therapeutic manage-
ment, as surgical treatment is rarely indicated. The
management may include: patient reassurance and
education, medical, surgical and/or psychological
treatments.
Urgent surgical intervention should be recom-
mended for known or highly suspected nerve injury,
and those related to endodontic or implant nerve
injury. Later surgical intervention for hypoaesthetic
nerve injuries does not return the patient to normal-
ity43,44 and surgery for patients with pain and hyper-
aesthesia is not appropriate as the pain is not abated
and patients are faced with long term antiepileptics
or antidepressants for chronic pain.13
Sharp blunt discrimination 
Using a dental probe sharp and blunt ends, the unaffected side is tested 
first. A minimum of five stimulations would be used and the number 
recognized by the patient (if less than 3 out of 5 then the test is 
negative). Whilst this test can illustrate hypoaesthesia with reduced 
sharp detection on the affected side, this test can also identify 
mechanical hyperalgesia (increased pain on sharp stimulation) which is 
often extremely uncomfortable for the patient. Sharp thresholds can be 
estimated using specially designed algometers not used in this study. 
 
 
 
Two-point discrimination (TPD) 
Using college forceps with beaks open and closed (both for five 
stimulations), TPD function can be estimated. Some authors prefer 
specially designed calipers which can be set to a specific distance. 
Normal TPD in the V3 dermatome extraorally ranges from 2-4mm on the 
lip vermillion to 6-8mm on the skin of the chin. 
 
 
 
Figure 2 Continued.
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LA, orthognathic, trauma and non-traumatic
(chemotherapy, radiation, secondary to
systemic disease and neoplastic local disease)
nerve injuries
Evidence base remains limited for managing these
nerve injuries, we only know that there is no ‘magic
bullet’ to fix them. A ‘sit and wait’ approach has to
be adopted with reassurance of the patient. Thera-
peutic management of the symptoms should be initi-
ated based on the clinical presentation.
• Homecheck – If you cause extreme (funny bone)
pain during an intervention, for example an injec-
tion, root canal treatment, extraction or implant
preparation in your patient do follow them up the
next day and check they are OK. If the patient
reports numbness, altered sensation and or pain,
reassure them, acknowledge their complaints with-
out minimising and arrange review.
• Continue to support and reassure your patient and
advise them to visit to confirm the presence of neu-
ropathy. If the neuropathy affects most of the der-
matome +/- associated with severe neuropathic pain
nerve injury must be suspected. Reassure your
patient that 75% of these injuries resolve.
• Say sorry as this is not an admission of guilt.
• Initiate medical management (recommended for
other peripheral sensory nerve injuries)
◦ High dose oral NSAIDs (400–800 mg Ibuprofen
PO QDS) for 2 days only. Bandolier Oxford league
table summarises the optimal analgesia for post-
operative pain and combined ibuprofen and
paracetamol have the smallest number needed to
be treated.52
◦ GMP prescription for prednisolone 5-day step-
down dose of 50-40-30-20-10 mg PO (not for
patients with contraindications for steroids or
NSAIDs).
◦ Vitamin B complex (Riboflavin 400 mg once
daily for maximum of 3 months plus other vit B
complex).53
• Arrange a review of the patient. All advice is sum-
marised on the Trigeminalnerve.org.uk website.
• Long-term management of patients with non-re-
solving LA nerve injuries. The reality for these
patients is that if they have persistent neuropathic
pain, they have to be treated as such with psycho-
logical and medical management. Topical local
anaesthetic (lidocaine 5%) patches may assist the
patient in sleeping and playing sports in cold
weather.54 Psychological interventions play a signifi-
cant role in managing these patients and recom-
mendations for treatment of trigeminal neuropathic
pain are also well described by Renton and Zakz-
rewska.55
Summary of type and timing of
management
Management of third molar related nerve injuries
will depend upon the presentation of the patient
(pain, functional and psychological implications),
duration and cause of the nerve injury (Fig. 3).45,56
It is recognised that neuropathic pain does not
respond to surgical intervention thus prevention and
early management are paramount in preventing
chronic life-long pain after routine surgery in these
patients. Advice is summarised on the Trigeminal-
nerve.org.uk website.
The patient with the nerve injury must be treated,
not the nerve injury in isolation. The neuropathy,
pain, numness or pareasthesia, with associated func-
tional and psychological impact will be the driving
force behind the patient seeking treatment.56 These
factors must be assessed and the potential outcomes,
good or bad, be discussed and agreed with the
patient.
Patients sustaining LA, orthognathic, oncology and
trauma related nerve injuries will mainly be man-
aged therapeutically.57–61
Overall there is poor evidence to support late sur-
gical intervention for trigeminal nerve injuries.62,63
Most studies report on repair procedures undertaken
too late and early repair is imperative to minimise
central irreversible changes and possibly chronic
pain. Generally surgical repair of the trigeminal
nerves never returns the patient to preoperative
neural function, in addition, there is a risk of making
a numb patient (without pain) into one with PTNP
(with neuropathic pain).43,44 As with other post-
trauma sensory neuropathies it is recognised that
immediate repair is optimal,64,65 however, this rarely
is applied to dental nerve injuries with the miscon-
ception that we should sit and wait for resolution
resulting in long delays before surgical interven-
tion.66–68 Referral to a skilled microsurgeon is prefer-
ably done in time.
Some recent studies have highlighted immediate
repair with cadaveric treated human nerve graft
sucessful in managing various sized defects in
planned resection of nerves related to benign
tumour resection or trauma.68–70
Recent reports have also concluded, similar to
other surgical sites, that neuropathic pain does not
resolve with surgery, this being the main driver for
surgical repair.43,71
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Many reports have recommended the use of con-
duits (venous, prosthetic), sural nerve grafts and other
techniques without sufficient evidence and many
with poor ouctomes including neuropathy and pain
from the donor sites.72 The future may prove that
nerve growth factors, other growth promoting chemi-
cal, anti neuropathic pain agents and specialised con-
duits may play a role in improving repair of trigeminal
nerve injuries. The overall conclusions from reviews
in this area, is that we have a lot of evidence base to
harness. The singular consensus is that prevention of
these nerve injuries is possible and optimal.
The timing of intervention and mechanism of
injury are paramount in decision making in treat-
ment of trigeminal nerve injuries (summarised in
Fig. 3).
1. Counselling is the most useful effective tool for
managing patients with problematic permanent sen-
sory nerve injuries.
2. Medical intervention is indicated for patients with
pain or discomfort or with anxiety and or depression
in relation with chronic pain.73 However, due to the
multiple noxious side effects of chronic pain medica-
tion, <18% of patients remain adherent with medi-
cation
• Acute (medical)
• Late (chronic pain management with psycho-
logical interventions)
3. Surgical intervention is indicated for:
• Immediate surgical repair for suspected or known
nerve injury or intended surgical defect after
removal of benign tumour or recent trauma.60
• Immediate removal of the implant after an
implant related injury with post-operative neu-
ropathy with or without neuropathic pain.59,74
• Explorative surgery within 36 h if related to
development of neuropathy after overfill of root
canal-treated tooth.75–77
Medical intervention
Timeline During surgery    Post surgery   2 -6 weeks       12 weeks   > 12 weeks
Known or 
suspected 
nerve Inferior 
alveolar or 
lingual injury
Duty of 
candour 
inform patient 
immediately
Repair nerve 
immediately
Or refer for 
immediate 
repair to a
specialist 
centre 
Post M3M surgery
Patient presents with nerve injury
early postoperatively
Confirm extensive dermatome 
affected, anaesthesia, +/–
paraesthesia, +/– neuropathic pain
Inferior alveolar nerve DPT confirms 
retained roots or bony defect of IDC
Lingual nerve (buccal approach) DPT 
confirms retained roots CBCT 
confirms lingual plate defect due to 
M3M surgery
Consider early exploration (IAN via 
M3M socket) +/– nerve repair 
dependent upon surgical findings
Persistent non-
resolving lingual nerve 
injury after lingual 
access (lingual 
retraction +/–lingual 
split) surgery
Confirm extensive 
dermatome affected, 
anaesthesia, +/–
paraesthesia, +/–
neuropathic pain
Consider exploration 
within 12 weeks +/–
nerve repair 
dependent upon 
surgical findings
Patient presents with 
persistent non-resolving 
Inferior alveolar nerve 
injury or lingual nerve 
injury after M3M surgery 
Confirm extensive 
dermatome affected, 
anaesthesia, +/–
paraesthesia, +/–
neuropathic pain
Consider medical and 
psychological therapeutic 
measures.
N.B Surgical repair DOES 
NOT IMPROVE neuropathic 
pain
New developments
MRI micro neurography may assist in confirmation of damage to IAN and LN (currently available in US, under development in London and Belgium). 
Larger IAN defects can be optimally repaired using Axogen cadaveric nerve graft (currently NICE approved for hand surgery in UK)
High risk nerve injury or patient with
high risk of developing neuropathic 
pain: consider pre-emptive 
amitriptyline or pregabalin
Reported neuropathy immediate post -surgery 
NSAIDs ibuprofen 6—mg TDS 5 days (MH 
permitting)
step down prednisolone 50-10 mg over 5 days 
(exclude known risk of DU and or PU)
Vitamin B complex (long term during recovery)
If required: psychological support (for PTSD and sleep disorders) 
and therapeutic management of neuropathic pain (NICE 
Guidance Neuropathic Pain in adults) 
Step 1: amitriptyline or nortriptyline
Step 2: gabapentin or pregabalin
Adjunctive topical agents (lidocaine, capsaicin)
Post implant or endodontic 
surgery
Patient presents with nerve 
injury early postoperatively
Confirm extensive 
dermatome affected, 
anaesthesia, +/–
paraesthesia, +/–
neuropathic pain
Within 30 hours
Remove implant or 
endodontically treated 
tooth and reassess patient
combined with medical 
intervention above
Post local 
anaesthesia or 
orthognathic 
surgery or 
trauma
Duty of 
candour 
inform patient 
immediately
Surgery not 
indicated
Medical and 
psychological 
therapies
Surgical intervention
MANAGEMENT OF TRIGEMINAL NERVE INJURIESRELATED TO DENTAL AND OROMAXILLOFACIAL PROCEDURES
Psychological intervention
Figure 3 Algorithm for management of trigeminal nerve injuries related to dental and oromaxillofacial procedures.
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• Within 2–4 weeks if clinical presentation of per-
sistent neuropathy is paramount. Radiographic
follow-up is not necessary however if there is
cone beam computed tomography (CBCT) evi-
dence of breach of lingual plate or IDC consider
immediate action: nerve exploration+/- repair;
◦ Lingual nerve neuropathy patients with
CBCT evidence of damage to lingual plate adja-
cent to third molar surgical site.
◦ Inferior alveolar nerve with retained roots or
evidence of bone inclusions or compression of
IDC.
• Within 3 months of injury;
◦ Non-resolving lingual or inferior dental nerve
injuries. Exploratory surgery for lingual or infe-
rior alveolar nerve injuries within 3 months
post injury. Surgical intervention is not effective
for neuropathic pain.43,78 If this is the driving
force behind seeking surgery, surgical interven-
tion should be reconsidered.
Future directions
Exciting results were reported of allografting lingual
and IAN injuries. Using a pre-prepared human trea-
ted cadaveric allograft the inferior alveolar and lin-
gual nerve can be repaired with minimal tension.
This is undertaken using microscopy and described
in several publications by John Zuniga and Michael
Miloro.66,79,80 This is likely to be the treatment of
choice if repair is indicated and direct reanastomosis
cannot be undertaken most commonly for the IAN.
One of the main issues regarding nerve repair is the
early identification of the neuroma relating to the
patients’ symptoms, and the connectivity of the
nerve itself, that is, is the nerve actually functioning.
Recent developments with magnetic resonance neu-
rography has availed the surgeon to identify the
nerve lesion and neural functionality to facilitate
appropriate and earlier nerve repair intervention.48
Conclusions
This article was intended to acknowledge and share
some key issues around surgical trigeminal nerve
injuries including pathophysiology, diagnosis and
management. Unfortunately, many of the suggested
treatment options do not ‘fix’ the patient but aim to
manage their symptoms as best as possible, improve
function and allow them time to accommodate to
these unfortunate events, which is often not very
satisfactory.
Some key take home messages include:
• Neuropathic pain as well as altered sensation and
numbness is what most patients experience with
iatrogenic sensory nerve injury. This has a significant
and unpleasant effect on the patient (improve your
consent).
• The majority of iatrogenic nerve injuries are avoid-
able.
• Owing to the significant problems following nerve
injury, pre-operative strategies for minimising this
risk of nerve damage need to be considered care-
fully. Peri-operative planning, operative execution
and post-operative care needs improving to minimise
and hopefully abolish these injuries.
• Several strategies are presented to assist in pre-
venting nerve injuries.
• Inferior alveolar nerve injuries in relation to
implant and endodontic dentistry are permanent and
‘unfixable’ unless treated quickly within 30 h.
• There is a need for a consensus and standardisation
of risk assessment and management, a holistic
approach in managing the pain, related effect on
functionality and psychological implications caused
to the patients affected by iatrogenic nerve injury.
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